Lung Cancers Active Not Recruiting Phase 3 Trials for Crizotinib (DB08865)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02737501ALTA-1L Study: A Phase 3 Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-small Cell Lung Cancer (NSCLC) ParticipantsTreatment